English

MAIO, 23 e 24
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 48.3%
96.6

Biological products: 34.5%
69

Biosimilars: 20.7%
41.4

Hospital products: 34.5%
69

Innovative medicines: 55.0%
110

mais informações




Interesses estratégicos

In-licensing: 55.2%
110.4

Out-licensing: 46.6%
93.2

Co-marketing: 37.9%
75.8

Co-promotion: 37.9%
75.8

Co-development: 53.4%
106.8

mais informações




Área terapêutica

Cardiovascular: 51.7%
103.4

CNS: 50.0%
100

Infectious diseases: 32.8%
65.6

Pain: 48.3%
96.6

Respiratory: 36.2%
72.4

mais informações



PARTICIPANTES 2019

Allergy/immunology: 19.8%

Cardiovascular: 51.7%

CNS: 50.0%

Dentistry: 2.6%

Dermatology: 18.1%

Drug delivers technol.: 23.3%

Gastroenterology: 22.4%

Gerontology: 11.2%

Gynecology: 22.4%

Infectious diseases: 32.8%

Hematology: 10.4%

Ophthalmology: 13.8%

Oncology: 18.1%

Orthopedics: 17.2%

Pain: 48.3%

Pediatrics: 15.5%

Psychiatrics: 19.0%

Respiratory: 36.2%

Rheumatology: 16.4%

Urology: 17.2%

Vaccines: 10.3%

Patrocinador

patrocinador

apoio